Annual long term liabilities:
$226.34M+$129.25M(+133.12%)Summary
- As of today (July 4, 2025), RXRX annual total long term liabilities is $226.34 million, with the most recent change of +$129.25 million (+133.12%) on December 31, 2024.
- During the last 3 years, RXRX annual long term liabilities has risen by +$205.59 million (+990.87%).
- RXRX annual long term liabilities is now -53.02% below its all-time high of $481.77 million, reached on December 31, 2020.
Performance
RXRX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$229.31M+$2.96M(+1.31%)Summary
- As of today (July 4, 2025), RXRX quarterly total long term liabilities is $229.31 million, with the most recent change of +$2.96 million (+1.31%) on March 31, 2025.
- Over the past year, RXRX quarterly long term liabilities has increased by +$146.53 million (+177.02%).
- RXRX quarterly long term liabilities is now -52.40% below its all-time high of $481.77 million, reached on December 1, 2020.
Performance
RXRX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RXRX Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +133.1% | +177.0% |
| 3 y3 years | +990.9% | +47.9% |
| 5 y5 years | +3.4% | - |
RXRX Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +990.9% | at high | +177.0% |
| 5 y | 5-year | -53.0% | +990.9% | -52.4% | +1278.8% |
| alltime | all time | -53.0% | +990.9% | -52.4% | +1278.8% |
RXRX Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $229.31M(+1.3%) |
| Dec 2024 | $226.34M(+133.1%) | $226.34M(+143.2%) |
| Sep 2024 | - | $93.05M(-11.7%) |
| Jun 2024 | - | $105.33M(+27.2%) |
| Mar 2024 | - | $82.78M(-14.7%) |
| Dec 2023 | $97.09M(-15.7%) | $97.09M(-1.7%) |
| Sep 2023 | - | $98.74M(+17.9%) |
| Jun 2023 | - | $83.78M(-20.2%) |
| Mar 2023 | - | $105.04M(-8.8%) |
| Dec 2022 | $115.22M | $115.22M(-18.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $140.46M(+1.6%) |
| Jun 2022 | - | $138.28M(-10.8%) |
| Mar 2022 | - | $155.05M(+647.3%) |
| Dec 2021 | $20.75M(-95.7%) | $20.75M(+24.8%) |
| Sep 2021 | - | $16.63M(-36.9%) |
| Jun 2021 | - | $26.34M(-94.5%) |
| Mar 2021 | - | $478.12M(-0.8%) |
| Dec 2020 | $481.77M(+120.0%) | - |
| Dec 2020 | - | $481.77M |
| Dec 2019 | $219.01M | - |
FAQ
- What is Recursion Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual long term liabilities year-on-year change?
- What is Recursion Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Recursion Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of RXRX is $226.34M
What is the all time high annual long term liabilities for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual total long term liabilities is $481.77M
What is Recursion Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, RXRX annual total long term liabilities has changed by +$129.25M (+133.12%)
What is Recursion Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of RXRX is $229.31M
What is the all time high quarterly long term liabilities for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly total long term liabilities is $481.77M
What is Recursion Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, RXRX quarterly total long term liabilities has changed by +$146.53M (+177.02%)